Skip to main content

Surgical Robotics Market is anticipated to grow with a robust CAGR of 10.2% between 2021-2031

 Surgical robotic systems primarily include surgical systems (capital equipment), instruments & accessories, and services (maintenance and up-gradation). In the past decade, the definition of these advanced technologies has expanded, involving the use of these systems for multiple surgical procedures ranging from general surgeries to orthopedic surgeries. The ongoing trend of rising demand for surgical robotic systems is anticipated to continue in the future with the implementation of technological innovations and advancements in minimally invasive surgical procedures.

Owing to the rapid technological advances in the field of surgical robotics and its increasing adoption across different healthcare facilities, as depicted in the preceding figure, the overall market size is anticipated to grow at the CAGR of 10.2% during the forecast period 2021-2031. The surgical systems segment is anticipated to generate a value of $16,774.5 million in 2031.



Market Segmentation • Product Type: Surgical Systems, Instruments & Accessories, and Services • Application: General Surgery, Urology Surgery, Gynecology Surgery, Orthopedic Surgery, Cardiology Surgery, Head & Neck Surgery, and Others • End-User: Hospitals, Ambulatory Surgical Centers, and Specialty Clinics Regional Segmentation • North America: U.S. and Canada • Europe: Germany, U.K, France, Italy, Spain, Turkey, Russia, Belgium, Switzerland, Sweden, Netherlands, Denmark, Norway, Finland, Austria, Ireland, Rest-of-Europe • Asia-Pacific: Japan, China, India, South Korea, Australia & New Zealand, Taiwan, Thailand, Malaysia, Singapore, Indonesia, and Philippines • Latin America: Brazil, Mexico, Argentina, chile, Venezuela, Colombia, Puerto Rico, Panama, and Uruguay • Rest-of-the-World: Kingdom of Saudi Arabia, Israel, Qatar, Pakistan, Kuwait, Egypt, and Lebanon Growth Drivers • Rising Incidence of Chronic Disorders Inciting the Use of Robotic-Assisted Surgical Procedures • Elevating Geriatric Population Changing the Adoption Patten for Minimally Invasive Surgical Procedures • Rising Demand of Minimally Invasive Surgical Procedures Signifies the Need for Robotic-Assisted Surgeries • Technological Advancement in the Field of Medical Surgeries Market Challenges • High Cost of Surgical Robotic Systems and its Associated Procedures • Shortage of Skilled Professionals • Restrictive Reimbursement Landscape Market Opportunities • Development of Low-Cost Surgical Robotic Systems • Implementation of Artificial Intelligence (AI) in Surgical Robots • Development of Surgical Simulators for the Training of Professionals Market Trends • Operating Lease Programs Implemented by the Surgical Robotic Manufacturers Key Companies Profiled Asensus Surgical, Inc., avatera medical GmbH, CMR Surgical Limited, Corin Group, Curexo, Inc., Globus Medical, Inc., Intuitive Surgical, Inc., Johnson & Johnson, Medicaroid Corporation, Medrobotics Corporation, Medtronic plc, meerecompany, Inc., Monteris Medical Corporation, Neocis, Inc., PROCEPT BioRobotics Corporation, Renishaw plc, Siemens Healthineers AG, Smith & Nephew plc, Stereotaxis, Inc., Stryker Corporation, THINK Surgical, Inc., Titan Medical, Inc., Venus Concept, Inc., Vicarious Surgical, Inc., Virtual Incision Corporation, and Zimmer Biomet Holdings, Inc.

Request a Sample-https://bisresearch.com/requestsample?id=1110&type=download

Labels:

Comments

Post a Comment

Popular posts from this blog

Microbiome Therapeutics Market Growth, Segmentation, Opportunity and Forecast to 2032

  Global microbiome therapeutics market is expected to grow further in the coming years due to the continuous increase in awareness and need for better and safer treatment alternatives and the dominance of gastrointestinal (GI) and infectious diseases segment can be attributed to the existing dominance of microbiome therapeutics available for a variety of indications ranging from diarrhea and gut dysbiosis to skin disorders, cancer indications among others. The global microbiome therapeutics market which accounted for $306.3 million in 2021 is expected to reach $3,204 million by 2032, reporting a CAGR of 24.95% during the forecast period 2022-2032. The existing   microbiome therapeutics market    is favored by multiple factors, including the rising geriatric populations coupled with the increasing adoption of inorganic growth strategies by key players in the market. Impact of COVID-19 There were numerous consequences due to the COVID-19 pandemic, especially...
Post a Comment
Read more

PD-1/PDL-1 Inhibitor Market Growth Prospects, Emerging Trends and Forecast to 2032

  PD-1/PDL-1 inhibitors are immune-therapeutic agents used in the treatment of various cancer indications, mostly in the advanced stages. PD-1/PDL-1 inhibitors are monoclonal antibodies majorly of IgG1 and IgG4 types to be administered to patients via injection The current market already has seven approved products in the U.S. and a large number of research activities are currently undergoing in this segment generating interest of commercial as well as academic research institutions. In the current period of precision medicine and providing targeted treatment, identification of target patient has become very important as well as complicated. With the emergence of diagnostic test identifying predictive biomarkers, the selection and administration of targeted treatment has become comparativlely conveninent and efficient. PD-1/PDL-1 inhibitors market   are majorly indicated for the treatment of advanced cases of different cancer indications. The PD-1/PDL-1 inibitor treatment has ...
Post a Comment
Read more

Ligase Market Opportunities, Strategies, Share, Segmentation, In-depth Analysis 2032

  The global ligase market is progressing rapidly with a significant increase in the research and development activities pertaining to a wide range of ligase product for disease detection, accentuating their criticality in healthcare. Ligase enzyme has a critical role in the molecular diagnostics approach, as it ensures the safe and effective application of targeted therapeutics. Most of the players in the global ligase market offer products encompassing the ligation kits and enzymes. The global  ligase market  is projected to reach $651.4 million by 2032 from $371.2 million in 2021, at a CAGR of 5.29% during the forecast period 2022-2032. The growth in the global ligase market is expected to be driven by factors such as the increasing prevalence of infectious and genetic diseases on a global level, rising awareness of enzyme based diagnostic testing and significant number of funding for executing research and development.   Impact Several techniques are employed in ...
Post a Comment
Read more